Approval · Notice of Compliance 34650 · 2025
ALENDRONATE: Notice of Compliance 34650
Issued January 8, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34650
- Date
- January 8, 2025
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Canadian reference product
- FOSAMAX (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALENDRONATE | Not yet assigned | — |
Medicinal ingredients
- ALENDRONATE SODIUM 70 MG per TAB